High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult height

European Journal of Endocrinology

Volumn 162, Issue 4, 2010, Pages 653-660

  Van Gool, S A ^a   Kamp, G A ^b   Odink, R J ^c   De Muinck Keizer Schrama, S M P F ^d   Delemarre van De Waal, H A ^a,e   Oostdijk, W ^a   Wit, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Tergooi Hospitals ^*  (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ACCELERATION; AGE; ARTICLE; BODY HEIGHT; BONE MATURATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT STATURE; TREATMENT DURATION; TREATMENT RESPONSE;

BODY HEIGHT; BODY MASS INDEX; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; LINEAR MODELS; MALE; NETHERLANDS; PUBERTY; YOUNG ADULT;

EID: 77950309285     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0880     Document Type: Article

References (30)

1. Wit JM, Reiter EO, Ross JL, Saenger PH, Savage MO, Rogol AD & Cohen P. Idiopathic short stature: management and growth hormone treatment. Growth Hormone & IGF Research 2008 18 111-135.
2. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO & Wit JM on behalf of the 2007 ISS Consensus Workshop Participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. Journal of Clinical Endocrinology and Metabolism 2008 93 4210-4217.
3. Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P & Reiter EO on behalf of the KIGS International Board. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Hormone Research 2007 68 53-62.
4. Lesage C, Walker J, Landier F, Chatelain P, Chaussain JL & Bougneres PF. Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. Journal of Pediatrics 1991 119 29-34.
5. Bourguignon JP, Vandeweghe M, Vanderschueren-Lodeweyckx M, Malvaux P,Wolter R, Du Caju M & Ernould C. Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty. Journal of Clinical Endocrinology and Metabolism 1986 63 376-382.
6. Rikken B, Massa GG & Wit JM. Final height in a large cohort of Dutch patients with growth hormone deficiency treated with growth hormone. Dutch Growth Hormone Working Group. Hormone Research 1995 43 135-137.
7. Rekers-Mombarg LT, Kamp GA, Massa GG & Wit JM. Influence of growth hormone treatment on pubertal timing and pubertal growth in children with idiopathic short stature. Dutch Growth Hormone Working Group. Journal of Pediatric Endocrinology and Metabolism 1999 12 611-622.
8. Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SMPF, Delemarre-Van de Waal HA, Verhoeven-Wind L, Zwinderman AH & Wit JM. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Archives of Disease in Childhood 2002 87 215-220.
9. Kamp GA, Zwinderman AH, Van Doorn J, Hackeng W, Frölich M, Schönau E & Wit JM. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH. Clinical Endocrinology 2002 57 315-325.
10. Kamp GA, Ouwens DM, Hoogerbrugge CM, Zwinderman AH, Maassen JA & Wit JM. Skin fibroblasts of children with idiopathic short stature show an increased mitogenic response to IGF-I and secrete more IGFBP-3. Clinical Endocrinology 2002 56 439-447.
11. Roede MJ & van Wieringen JC. Growth diagrams 1980. Netherlands third nationwide survey. Tijdschrift voor Sociale Gezondheidszorg 1985 63 1-34.
12. Usher R & McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. Journal of Pediatrics 1969 74 901-910.
13. Gerver WMJ & De Bruin R. Paediatric Morphometrics: A Reference Manual. Utrecht, The Netherlands: Bunge, 1996.
14. Fredriks AM, van Buuren S, Jeurissen SE, Dekker FW, Verloove-Vanhorick SP & Wit JM. Height, weight, body mass index and pubertal development reference values for children of Turkish origin in The Netherlands. European Journal of Pediatrics 2003 162 788-793.
15. Greulich WW & Pyle SI. Radiographic Atlas of Skeletal Development of Hand and Wrist, 2nd edn. Stanford: Stanford University Press, 1959.
16. Gijsbers AC, Lew JY, Bosch CA, Schuurs-Hoeijmakers JH, van Haeringen A, den Hollander NS, Kant SG, Bijlsma EK, Breuning MH, Bakker E & Ruivenkamp CA. A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities: test arrays first. European Journal of Human Genetics 2009 17 1394-1402.
17. Bayley N & Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. Journal of Pediatrics 1952 40 423-441.
18. van Buuren S & Ooms JC. Stage line diagram: an age-conditional reference diagram for tracking development. Statistics in Medicine 2009 28 1569-1579.
19. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP & Wit JM. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatric Research 2000 47 316-323.
20. Thodberg HH, van Rijn RR, Tanaka T, Martin DD & Kreiborg S. A paediatric bone index derived by automated radiogrammetry. Osteoporosis International 2009 In press. DOI: 10.1007/s00198-009-1085-9.
21. Hermanussen M & Cole J. The calculation of target height reconsidered. Hormone Research 2003 59 180-183.
22. Fredriks AM, van Buuren S, van Heel WJ, Dijkman-Neerincx RH, Verloove-Vanhorick SP & Wit JM. Nationwide age references for sitting height, leg length, and sitting height/height ratio, and their diagnostic value for disproportionate growth disorders. Archives of Disease in Childhood 2005 90 807-812.
23. Jorgensen JO, Flyvbjerg A & Christiansen JS. The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in growth hormone-deficient patients. Acta Endocrinologica 1989 120 8-13.
24. Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenäs L, Ivarsson SA, Jonsson B, Kriström B, Marcus C, Nilsson KO, Ritzén EM, Tuvemo T, Westphal O & Aman J. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 2008 93 4342-4350.
25. Fjellestad-Paulsen A, Simon D & Czernichow P. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment. Journal of Clinical Endocrinology and Metabolism 2004 89 1234-1239.
26. Gevers EF, Wit JM & Robinson IC. Growth, growth hormone (GH)-binding protein, and GH receptors are differentially regulated by peak and trough components of the GH secretory pattern in the rat. Endocrinology 1996 137 1013-1018.
27. Van den BJ & Wit JM. Anthropometry and body composition in children. Hormone Research 1997 48 33-42.
28. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH & Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Hormone & IGF Research 2008 18 89-110.
29. Rekers-Mombarg LT, Wit JM, Massa GG, Ranke MB, Buckler JM, Butenandt O, Chaussain JL, Frisch H & Leiberman E. Spontaneous growth in idiopathic short stature. Archives of Disease in Childhood 1996 75 175-180.
30. Wit JM & Rekers-Mombarg LT. Final height gain by GH therapy in children with idiopathic short stature is dose dependent. Journal of Clinical Endocrinology and Metabolism 2002 87 604-611.